| abstract |
The present invention relates to an implantable light therapy device which emits visible light in a specific wavelength band for a predetermined time period according to symptoms of a disease in a state in which the implantable light therapy device is fixed to a disease site, which occurs in tissue or an organ in the human body due to inflammation to suppress or reduce inflammation inducers (for example, interleukin 1 beta (IL-1β) and interleukin 18 (IL-18)). When the inflammation inducers (for example, IL-1β and IL-18) in a disease site generated due to the inflammation in the tissue or the organ of the human body are suppressed or reduced according to the present invention, inflammatory diseases (for example, Alzheimer's disease, Parkinson's disease, stroke, pancreatitis, rheumatoid arthritis) may be treated or prevented. |